QGEN
QIAGEN NV
NYSE · Healthcare · Medical - Diagnostics & Research · NL
$50.78
+0.78%Forward multiples
Based on analyst estimates
- P/E forward
- 20.02x
- P/E 2026E
- 20.91x
- P/E 2027E
- 19.43x
- P/E 2028E
- 17.75x
- P/S forward
- 4.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.04x
- PEG TTM
- 0.87x
- Price / book
- 3.12x
- Price / sales
- 4.99x
- Price / cash flow
- 16.02x
Enterprise value
- Enterprise value
- $11.3B
- EV / sales
- 5.40x
- EV / EBITDA
- 16.11x
- EV / EBIT
- 21.30x
- Market cap
- $10.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026